The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 1-benzyl-3-(4-methyl-2-pivalamidothiazol-5-yl)-1H-pyrazole-5-carboxylate ID: ALA1099214
PubChem CID: 46220952
Max Phase: Preclinical
Molecular Formula: C22H26N4O3S
Molecular Weight: 426.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1cc(-c2sc(NC(=O)C(C)(C)C)nc2C)nn1Cc1ccccc1
Standard InChI: InChI=1S/C22H26N4O3S/c1-6-29-19(27)17-12-16(25-26(17)13-15-10-8-7-9-11-15)18-14(2)23-21(30-18)24-20(28)22(3,4)5/h7-12H,6,13H2,1-5H3,(H,23,24,28)
Standard InChI Key: YGBBVYDQOPWHSA-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
-3.3124 -1.1013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4993 -1.2408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1136 -0.5114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6910 0.0815 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.4287 -0.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1350 -1.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1592 0.0978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1922 0.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9226 1.3057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4948 1.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7644 0.9793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5278 2.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8238 1.8460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2975 -0.3941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7224 -0.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0179 -0.6216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0994 0.1952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9126 0.3355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7476 -1.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7791 -1.8309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4458 -0.5670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1755 -0.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8737 -0.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3283 0.9007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0689 1.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3606 2.3295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0352 3.0445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8615 3.0702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2892 2.3598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8903 1.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
7 8 1 0
3 4 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 14 2 0
3 14 1 0
8 9 2 0
16 19 1 0
4 5 1 0
19 20 2 0
8 10 1 0
19 21 1 0
5 1 2 0
21 22 1 0
10 11 1 0
22 23 1 0
1 2 1 0
17 24 1 0
10 12 1 0
24 25 1 0
2 6 1 0
25 26 2 0
10 13 1 0
26 27 1 0
14 15 1 0
27 28 2 0
28 29 1 0
5 7 1 0
29 30 2 0
30 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 426.54Molecular Weight (Monoisotopic): 426.1726AlogP: 4.52#Rotatable Bonds: 6Polar Surface Area: 86.11Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.87CX Basic pKa: ┄CX LogP: 4.95CX LogD: 4.83Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.59Np Likeness Score: -1.78
References 1. Ye L, Knapp JM, Sangwung P, Fettinger JC, Verkman AS, Kurth MJ.. (2010) Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles., 53 (9): [PMID:20373765 ] [10.1021/jm100235h ]